RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours

NCT03199872 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: RV001V

Sponsor

RhoVac APS

Collaborators

[object Object]